MedPath

Glyburide

GLYBURIDE TABLETS USP Rx only

Approved
Approval ID

c23cfac8-bfa5-95f4-e053-2a95a90aab0f

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

May 13, 2021

Manufacturers
FDA

NuCare Pharmaceuticals,Inc.

DUNS: 010632300

Products 1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

Glyburide

PRODUCT DETAILS

NDC Product Code68071-2402
Application NumberANDA206483
Marketing CategoryC73584
Route of AdministrationORAL
Effective DateMay 13, 2021
Generic NameGlyburide

INGREDIENTS (5)

LACTOSE MONOHYDRATEInactive
Code: EWQ57Q8I5X
Classification: IACT
CELLULOSE, MICROCRYSTALLINEInactive
Code: OP1R32D61U
Classification: IACT
MAGNESIUM STEARATEInactive
Code: 70097M6I30
Classification: IACT
SODIUM STARCH GLYCOLATE TYPE A POTATOInactive
Code: 5856J3G2A2
Classification: IACT
GLYBURIDEActive
Quantity: 5 mg in 1 1
Code: SX6K58TVWC
Classification: ACTIB

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

Glyburide - FDA Drug Approval Details